Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 15 November 2007. doi:10.1136/ard.2007.074948
Annals of the Rheumatic Diseases 2008;67:1111-1115
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2007.074948v1
ard.2007.074948v2
67/8/1111    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kling, A
Right arrow Articles by Padyukov, L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kling, A
Right arrow Articles by Padyukov, L

EXTENDED REPORTS

Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis

A Kling 1, M Seddighzadeh 2, L Ärlestig 3, L Alfredsson 4,5, S Rantapää-Dahlqvist 3, L Padyukov 2

1 Division of Clinical Pharmacology, University Hospital, Umeå, Sweden
2 Rheumatology Unit, Department of Medicine, Karolinska Institutet/Karolinska University Hospital, Stockholm, Sweden
3 Department of Public Health and Clinical Medicine, Rheumatology, University Hospital, Umeå, Sweden
4 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
5 Stockholm Center for Public Health, Karolinska University Hospital, Stockholm, Sweden

Correspondence to:
A Kling, Division of Clinical Pharmacology, University Hospital, SE-901 85 Umeå, Sweden; anders.kling{at}pharm.umu.se

Objectives: To analyse the association between the genetic polymorphisms within the HTR2A gene for the serotonin receptor and rheumatoid arthritis (RA).

Methods: HTR2A gene polymorphisms were analysed in patients with RA and controls from two study populations using PCR based restriction endonuclease mapping or TaqMan allelic discrimination with more than 4000 individuals included in the current study.

Results: At the discovery stage we detected significant differences in frequency of rs6313 (T102C polymorphism) between the patients with RA and controls (p = 0.006). Following validation with an extended set of single nucleotide polymorphisms (SNPs) and number of DNA samples, a trend in associations in allelic model for SNPs rs6314, rs1328674, rs6313 and rs6311 (p = 0.006, 0.002, 0.006, 0.009) was seen, although it was lost after correction for multi-comparison for all but rs1328674 (empirical p value = 0.021). However, haplotype frequency analysis based on these four SNPs showed significantly low representation of TCTT combination in patients with RA in comparison with controls (3.6% and 5.6%, p<0.001 on {chi}2 test, empirical p = 0.004 after 100 000 permutations) and a significantly higher frequency of CTCC combination in patients with RA in comparison with controls (3.6% and 2.2%, p = 0.002 on {chi}2 test, empirical p = 0.022 after 100 000 permutations).

Conclusions: In our study, genetic polymorphisms at the HTR2A gene are associated with susceptibility for RA, suggesting possible links between the serotonergic system and development of the disease.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism